Literature DB >> 30746257

EGFR L747P mutation in one lung adenocarcinoma patient responded to afatinib treatment: a case report.

Tong Zhou1, Xiaoyue Zhou1, Peng Li1, Chuang Qi2, Yang Ling1.   

Abstract

Entities:  

Year:  2018        PMID： 30746257      PMCID： PMC6344738          DOI： 10.21037/jtd.2018.12.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.

Authors:  Takahiro Yoshizawa; Ken Uchibori; Mitsugu Araki; Shigeyuki Matsumoto; Biao Ma; Ryo Kanada; Yosuke Seto; Tomoko Oh-Hara; Sumie Koike; Ryo Ariyasu; Satoru Kitazono; Hironori Ninomiya; Kengo Takeuchi; Noriko Yanagitani; Satoshi Takagi; Kazuma Kishi; Naoya Fujita; Yasushi Okuno; Makoto Nishio; Ryohei Katayama
Journal:  NPJ Precis Oncol       Date:  2021-04-16

2.  The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors.

Authors:  Guangjian Yang; Chengming Liu; Jiaqi Hu; Yang Sun; Peizeng Hu; Liu Liu; Haiyan Xu; Dazhou Li; Weihua Li; Yaning Yang; Nan Sun; Jie He; Yan Wang
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

3.  Systemic and Intracranial Efficacy of Osimertinib in EGFR L747P-Mutant NSCLC: Case Report.

Authors:  David E Gerber; Melissa Mayer; Jeffrey Gagan; Mitchell S von Itzstein
Journal:  JTO Clin Res Rep       Date:  2022-02-15

4.  Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases.

Authors:  Yibin Li; Weixi Guo; Bin Jiang; Chengkun Han; Feng Ye; Jingxun Wu
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

Review 5.  Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review.

Authors:  Emma-Anne Karlsen; Sam Kahler; Joan Tefay; Shannon R Joseph; Fiona Simpson
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

Review 6.  Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells.

Authors:  Abdulaziz B Hamid; Ruben C Petreaca
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.